더말 필러 시장 : 예측(2023 -2028년)

The dermal fillers market is projected to grow at a CAGR of 8.57%, reaching US$5.597 billion in 2028 from US$3.148 billion in 2021. Dermal fillers are cosmetic injections given to customers seeking to enhance and alter the current appearance of their faces. Dermal fillers are a standard procedure opted for by consumers who wish to reduce the sagging appearance of their facial skin, uplift the facial appearance, increase the mass, or enhance the symmetry of their facial features such as cheeks, lips, and jawlines. An extensive range of different types of dermal fillers is available for consumers through dermatology clinics, hospitals, and medical spas. The customers can notice immediate results and based on the type of dermal filler opted for, the results might be effective for a few months or years.

Dermal fillers are gaining popularity due to their efficiency in restoring the aging signs of the patient's skin and adding extra volume to the targeted facial part. For instance, the Juvederm dermal filler by Kaya Clinic in India guarantees immediate results to its customer within one week of injecting it into the skin. Various skin concern factors such as sun damage, fine lines, wrinkles, sunken eyes, and skin discoloration result from the loss of volume in the face tissues. By injecting dermal fillers, the user can benefit from reducing the appearance of all such skin concerns. Apart from this, the dermal fillers help construct collagen and elastin content in the injected area, which are beneficial to restore the skin's health. Even though there are several skincare products and regimens which can opt for by consumers, the result offered by dermal fillers is of superior quality, due to which the international dermal fillers market is witnessing an increased market size.

An increasing number of low-risk non-surgical, and minimally invasive procedures are expected to boost the market growth.

The dermal fillers injected into the patient's skin are non-surgical procedures. Therefore, it is a minimally invasive procedure that does not require its customer to undergo a cosmetic operation or receive anesthesia to achieve the desired outcome. The annual report released by The Aesthetic Society highlighted that the number of dermal filler procedures in 2021 amounted to approximately 1.8 million, whereas other skin tightening treatment procedures amounted to 0.39 million. This demonstrates interest in dermal fillers owing to their various face enhancement benefits and low-risk features. Therefore, considering these key factors driving demand for the dermal filler market, it can be anticipated that it will continue to expand its market size over the forecast period.

The intense competition offered by similar cosmetic procedures will likely restrain the growth of the dermal fillers market.

Apart from dermal fillers, there are several cosmetic procedures and skin care services that provide similar results as dermal fillers. Botox, radio frequency-based face treatments, laser skin resurfacing method, micro-needling, and other facial revitalization treatments. Apart from these existing methods, pharmaceutical and skincare brands regularly innovate new techniques and treatments. For instance, ForeverSlender Medspa, a skin clinic based in the USA, has innovated a new non-surgical alternative for dermal fillers named Ultralift. Therefore, the existence of other options for derma fillers has the potential to slow down the expansion of the dermal fillers market.

Market Developments

• In June 2022, Croma Aesthetics Canada Ltd. introduced a new derma filler product, Saypha Volume Plus, with hyaluronic acid as its vital ingredient under its subsidiary brand Hugel Aesthetics. This derma filler targets restoring the original volume of the face.
• In June 2021, Medytox Inc. expanded its operations to Taiwan and announced a collaboration with Dynamic Medical Technologies Company to manufacture hyaluronic-acid-based dermal fillers.
• In February 2020, BioScience GmbH, specializing in the manufacture of aesthetic cosmetology products, introduced a new product line consisting of two new derma fillers of varying density levels.

North America is expected to hold a significant share of the universal dermal fillers market.

The increase in minimally-invasive cosmetic procedures across North American countries and the rise in skin clinic services and aesthetics are resulting in high demand and consumption of dermal fillers. Furthermore, the rising need for derma fillers and other cosmetic treatments is attracting branches of foreign companies into the North American market. For instance, Amalian, a German company specializing in high-end healthcare and skincare products, has announced its clinic's launch and superior-quality dermal fillers in Canada. In addition, healthcare and beauty companies in North America are actively investing in launching new products, including dermal fillers. For instance, AbbVie Company, a US-based pharmaceutical company, has been developing and launching new dermal filler product lines through its subsidiary brand, Allergan Aesthetics. Therefore, considering the factors influencing the rapid market growth of dermal fillers in North America, it can be anticipated that North America shall experience expansion in the dermal fillers market.

Market Segmentation

By Product Type

• Biodegradable
• Non-biodegradable

By Application

• Facial Line Correction
• Face Lift
• Lip Enhancement
• Others

By Material

• Hyaluronic Acid
• Calcium Hydroxylapatite
• Poly-L-Lactic Acid
• Polymethyl-Methacrylate Microspheres
• Others

By End-User

• Dermatology Clinics
• Hospitals
• Others

By Geography

• North America
  • USA
  • Canada
  • Mexico
• South America
  • Brazil
  • Argentina
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
• Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Vietnam
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base and Forecast Years Timeline

2. RESEARCH METHODOLOGY

• 2.1. Research Data
• 2.2. Research Design
• 2.3. Validation

3. EXECUTIVE SUMMARY

• 3.1. Research Highlights

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. DERMAL FILLERS MARKET BY PRODUCT TYPE

• 5.1. Introduction
• 5.2. Biodegradable
• 5.3. Non- Biodegradable

6. DERMAL FILLERS MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Facial Line Correction
• 6.3. Face Lift
• 6.4. Lip Enhancement
• 6.5. Others

7. DERMAL FILLERS MARKET BY MATERIAL

• 7.1. Introduction
• 7.2. Hyaluronic Acid
• 7.3. Calcium Hydroxylapatite
• 7.4. Poly-L-Lactic Acid
• 7.5. Polymethyl-Methacrylate Microspheres
• 7.6. Others

8. DERMAL FILLERS MARKET BY END-USER

• 8.1. Introduction
• 8.2. Dermatology Clinics
• 8.3. Hospitals
• 8.4. Others

9. DERMAL FILLERS MARKET BY APPLICATION

• 9.1. Introduction
• 9.2. Face
• 9.3. Full body

10. DERMAL FILLERS MARKET BY GEOGRAPHY

• 10.1. Introduction
• 10.2. North America
  • 10.2.1. USA
  • 10.2.2. Canada
  • 10.2.3. Mexico
• 10.3. South America
  • 10.3.1. Brazil
  • 10.3.2. Argentina
  • 10.3.3. Others
• 10.4. Europe
  • 10.4.1. Germany
  • 10.4.2. France
  • 10.4.3. United Kingdom
  • 10.4.4. Spain
  • 10.4.5. Others
• 10.5. Middle East And Africa
  • 10.5.1. Saudi Arabia
  • 10.5.2. UAE
  • 10.5.3. Israel
  • 10.5.4. Others
• 10.6. Asia Pacific
  • 10.6.1. China
  • 10.6.2. Japan
  • 10.6.3. India
  • 10.6.4. South Korea
  • 10.6.5. Indonesia
  • 10.6.6. Thailand
  • 10.6.7. Vietnam
  • 10.6.8. Others

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 11.1. Major Players and Strategy Analysis
• 11.2. Emerging Players and Market Lucrativeness
• 11.3. Mergers, Acquisitions, Agreements, and Collaborations
• 11.4. Vendor Competitiveness Matrix

12. COMPANY PROFILES

• 12.1. Sinclair
• 12.2. Suneva Medical
• 12.3. Merz Pharma
• 12.4. Abbvie Inc. (ALLEGRAN)
• 12.5. Galderma Laboratories, L.P.
• 12.6. Croma Pharma
• 12.7. Cytophil, Inc.
• 12.8. Humedix
• 12.9. Prollenium Medical Technologies